Linezolid Injection, Solution
Product Images NDC 65145-181

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 65145-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Linezolid-300ml-bag-label (Linezolid 300ml Bag Label)

Linezolid-300ml-bag-label (Linezolid 300ml Bag Label)
This is a description of a pharmaceutical product in an intravenous administration container. It contains linezolid and dextrose and is sterile and nonpyrogenic. The container should not be frozen, and leaks should be avoided to maintain sterility. The solution may exhibit a yellow color over time. The dosage and usage instructions should be followed as per the prescribing information. The infusion bags and ports do not contain natural rubber latex.*
FDA Label Image

Linezolid-300ml-pouch-label (Linezolid 300ml Pouch Label)

Linezolid-300ml-pouch-label (Linezolid 300ml Pouch Label)
This text provides details about a Linezolid Injection with a concentration of 600 mg/300 mL. It contains information on the composition of each mL, storage recommendations, and instructions for use. The product is sterile, nonpyrogenic, and comes in a single-dose container. It warns against using in series connections and emphasizes the sensitivity of Linezolid to light. Additionally, it mentions the product not containing natural rubber latex. The product is distributed by Caplin Steriles USA Inc. and made in India.*
FDA Label Image
FDA Label Image

Linezolid-figure-1 (Linezolid Figure 1)

Linezolid-figure-1 (Linezolid Figure 1)
This is a graph showing the linezolid plasma concentrations in micrograms per milliliter (g/mL) over time after a dose of 600 mg oral every 12 hours. The x-axis represents the time after the dose in hours, while the y-axis shows the plasma concentration in g/mL.*
FDA Label Image

Linezolid-structure (Linezolid Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.